PANRAX 40 IV

PANRAX 40 IV Specification

Indication
Peptic ulcer, Zollinger-Ellison syndrome, GERD, Gastric hypersecretory conditions

Dosage Form
Injection

Origin of Medicine
Allopathic

Salt Composition
Pantoprazole Sodium 40 mg

Pacakaging (Quantity Per Box)
1 vial

Drug Type
Generic

Ingredients
Pantoprazole Sodium Sesquihydrate

Physical Form
Liquid Injection

Function
Acid reducer, Proton pump inhibitor

Recommended For
Gastric ulcer, Acid reflux, Peptic ulcer, Gastroesophageal reflux disease (GERD)

Dosage
40 mg per vial

Dosage Guidelines
As directed by the physician, to be administered intravenously

Suitable For
Adults

Storage Instructions
Store below 25°C, protect from light and moisture

Marketed by
Panrax Pharmaceuticals

Method of Administration
Intravenous (IV) use only

Color
White to off-white powder

Onset of Action
Within 30-60 minutes after administration

Shelf Life
24 months from manufacturing date

Reconstitution
Dissolve content in 10 mL sterile water for injection before use

Prescription Status
Rx/Prescription required

Intended Use
Hospital and clinical setting

About PANRAX 40 IV

Pantoprazole 40 mg for injection is a proton pump inhibitor (PPI) used for short-term treatment of certain stomach and intestinal conditions caused by excessive acid production. The "DW" likely refers to Dextrose 5% in Water solution, which is used as a compatible solution to dilute the medication for intravenous (IV) infusion

Primary Uses

Pantoprazole injection is typically used when a patient cannot take oral medication, and its uses include:

Gastroesophageal Reflux Disease (GERD) with a history of erosive esophagitis: For short-term treatment (7 to 10 days) of inflammation and damage to the esophagus caused by stomach acid.
Zollinger-Ellison Syndrome: A condition where tumors cause the stomach to produce too much acid.
Peptic Ulcer Disease: Treatment and healing of painful sores in the stomach or intestine.
Stress Ulcer Prophylaxis: In critically ill patients to prevent stomach bleeding.